Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06399432
Status:
RECRUITING
Last Update Posted:
2024-05-03
First Post:
2024-04-30
Brief Title:
Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors
Sponsor:
Neil Korman
Organization:
University Hospitals Cleveland Medical Center
Study Overview
Official Title:
Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this study participants will have 3 or 4 total study visits over approximately 10 total weeks There is a two week medication washout period in between the 1st and 2nd visits This washout only applies if participants are using a prohibited psoriasis medication such as topical steroids or oral psoriasis medications like methotrexate During the washout period participants will have to stop the prohibited medications If participants are not using any prohibited medications then the 1st and 2nd visits can be combined and participants will only have 3 total in-person visits Participants will be randomly assigned by chance like flipping a coin to either the Mediterranean Diet or no dietary intervention After 4 weeks on the diet participants will start treatment with either Anti-IL-17 or Anti-IL-23 therapy The biologic treatments will prescribed by the participants regular dermatologist and not as a part of the study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None